Sign in
4

Changes in Ownership

agilon health, inc. Filed Acc 0001209191-22-025550

Chief Strategy & Dev. Officer sold 106,357 shares at an average $20.40 ($2,169,952)

  • Chief Strategy & Dev. Officer acquired 106,357 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Desai Veeral · Chief Strategy & Dev. Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-21 Exercise or conversion : show line 1 in the form +79,568 $1.00 $79,568 357,779 D
2022-04-21 Sale : show line 2 in the form −69,824 $20.43 $1,426,183 287,955 D
2022-04-21 Sale : show line 3 in the form −9,744 $21.35 $207,989 278,211 D
2022-04-22 Exercise or conversion : show line 4 in the form +26,789 $1.00 $26,789 305,000 D
2022-04-22 Sale : show line 5 in the form −26,789 $20.00 $535,780 278,211 D
Open-market sales · 106,357 sh · avg $20.40 · $2,169,952

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-04-21 Exercise or conversion : show line 6 in the form Options (Rights to Buy) −79,568 589,426 D
2022-04-22 Exercise or conversion : show line 7 in the form Options (Rights to Buy) −26,789 562,637 D
Loading xslF345X03/doc4.xml…